AAMG makes a foray into China's healthcare market

Singapore: With a view to cash-in on the huge demand for medical expertise in China, home-grown healthcare company Asian...

August 14, 2015 | Friday | News
A re-think on site staff competency training required

When drugs are trialed in patients, they move into a clinical setting in which the busy routine care of patients, rath...

September 5, 2013 | Thursday | Opinion
FDA to add 10 new drug inspectors in China

Singapore: In an effort to eliminate the weak industry oversight, the US drug regulatory body, the Food and Drug Adminis...

December 13, 2013 | Friday | News
Chinese luring Indian scientists to boost formulation business

Singapore: In a new trend, Chinese drugmakers have been hiring Indian scientists, with a view to boost the country's for...

September 2, 2015 | Wednesday | News
Nutrastar marks steady revenue in Q2, 2015

Singapore: China based healthcare product supplier, Nutrastar International, has marked revenue of $13.24 million in thr...

August 14, 2015 | Friday | Company results
WuXi Healthcare Ventures raises $290M

WuXi Healthcare Ventures announced the closing of its $290 million WuXi Healthcare Ventures II,exceeding its initial tar...

December 17, 2015 | Thursday | News
Is India losing to China in the investment race?

While both India and China - both have a billion plus population - present similar pictures in terms of opportunities an...

May 17, 2012 | Thursday | Analysis
WuXi AppTec, Fudan Uni to jointly research on genomics

Singapore: China's WuXi AppTec has partnered with Fudan University to bring WuXi NextCODE's population human genomics da...

June 8, 2015 | Monday | News
Start-up landscape in Southeast Asia

Singapore: The findings are surprising, mentions BVGH, as often it is the big pharmaceutical companies that invest larg...

April 30, 2015 | Thursday | Analysis
Asian firms lack antibody manufacturing capabilities

There are very few manufacturers in Asia capable of manufacturing antibodies on a large commercial scale. Manufacturing ...

October 4, 2012 | Thursday | Analysis
China hep B market to touch $1.4 bn by 2024'

Singapore: China will remain the largest major hepatitis B market over the next decade, rising from just under $923 mill...

March 1, 2016 | Tuesday | Analysis
BioSpectrum award winner Biomics uses RNAi for therapeutics

Biomics Biotechnologies, China, founded in February 2006, is on road to be counted as one of Asia's leading RNA interfer...

March 15, 2013 | Friday | Influencers
Heartbeat Experts expands in BRICK

Singapore: Heartbeat Experts, the global leader in stakeholder management solutions for the life sciences industry, ann...

December 13, 2012 | Thursday | News
Kotaro Yoshida: China, Japan are the new M&A hot spots

Compared to 2011, global pharmaceutical and biotechnology sectors suffered a setback in the number of mergers and acquis...

June 12, 2013 | Wednesday | Opinion
Taiwan, China firms to develop novel cancer molecule

Singapore: Taiwan-based GNT Biotech has got exclusive license from China-based Shenzhen Chipscreen Biosciences for the d...

October 10, 2013 | Thursday | News
Dyax, CVie to commercialize Kalbitor in China, HK

Singapore: Dyax and CVie Therapeutics, a subsidiary of Lee's Pharmaceutical Holdings, announced a strategic partnership...

February 8, 2013 | Friday | News
China: Is this an end to foreign monopoly?

Singapore: With 1.3 billion population and a burgeoning middle class, China has witnessed an unprecedented increase in ...

March 4, 2015 | Wednesday | Analysis
Amgen to open R&D units in Chinese univ

Singapore: Amgen and ShanghaiTech University, China, entered into a memorandum of understanding (MoU) to form a strategi...

September 26, 2013 | Thursday | News